NCT05222477

Brief Summary

Nocturia is the leading cause of sleep disruption with its subsequent negative impact on general health and QoL for a large proportion of the adult population. Nocturia is prevalent in men and women of all ages but may be particularly bothersome in younger adults, in whom the consequences of sleep disturbance may be more detrimental for daytime functioning and possibly for health and mortality.The underlying causes of nocturia obviously influence the efficacy of different treatment options. Because a major cause of nocturia is overproduction of urine at night, nocturia may not respond to treatments designed to reduce urgency and increase bladder capacity or increase urine flow, such as agents for the management of bladder outlet obstruction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

February 3, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2022

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

May 3, 2023

Status Verified

April 1, 2023

Enrollment Period

6 months

First QC Date

January 10, 2022

Last Update Submit

April 30, 2023

Conditions

Keywords

nocturiasleep deprivationsleep qualitytype 2 diabetes mellitus

Outcome Measures

Primary Outcomes (2)

  • Number of voids

    Number of times that the patient go for toilet per night for urination

    6 weeks

  • Sleep quality (0 is best, 3 is worst)

    data about sleep from Pittsburgh sleep quality index questionnaire

    6 weeks

Secondary Outcomes (1)

  • Abdominal and pelvic floor muscle electrical activity

    6 weeks

Study Arms (2)

Pelvic floor group

ACTIVE COMPARATOR

pelvic floor exercises (intervention) will be applied for patients with nocturia and type 2 DM for 6 weeks, 3 times/week

Behavioral: pelvic floor exercise

Abdominal group

ACTIVE COMPARATOR

Abdominal exercises (intervention) will be applied for patients with nocturia and type 2 DM for 6 weeks, 3 times/week

Behavioral: Abdominal muscles exercise

Interventions

pelvic floor exercises(intervention) will be applied for patients with nocturia and type 2 DM for 6 weeks, 3 times/week

Pelvic floor group

abdominal exercises (intervention) will be applied for patients with nocturia and type 2 DM for 6 weeks, 3 times/week

Abdominal group

Eligibility Criteria

Age45 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsNocturia is more prevalent in women with type 2 diabetes, therefore, we will include only females
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female Patients have had type II diabetes mellitus for more than 5years.
  • HbA1c value from 6.5% to7.5%.
  • Sleep deprivation for more than one month.
  • Medically stable patients
  • Blood glucose level from 130 to 150
  • Patients are not pregnant
  • Body mass index is 25 to 29.9 kg / m

You may not qualify if:

  • Unstable medical condition.
  • On antidepressors or anxiety treatment.
  • With ant musculoskeletal or neurological conditions that might interfere with the execution or the assessment of the exercise.
  • Cushing's disease (hypercortisolism) or Addison's disease (hypocortisolism).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alkasr Alaini hospitals

Cairo, Egypt

Location

MeSH Terms

Conditions

NocturiaSleep DeprivationSleep Initiation and Maintenance DisordersDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Lower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsDyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsMental DisordersSleep Disorders, IntrinsicDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Hady Atef, PhD

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of physical therapy

Study Record Dates

First Submitted

January 10, 2022

First Posted

February 3, 2022

Study Start

November 15, 2021

Primary Completion

May 15, 2022

Study Completion

June 1, 2022

Last Updated

May 3, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

We are planning to share the IPD on publication

Shared Documents
STUDY PROTOCOL
Time Frame
12 months
Access Criteria
We will provide this to the journal where we will submit our manuscript

Locations